Verrica Pharmaceuticals Inc. (VRCA) (CIK 0001660334) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001193125-25-326765
- Form
- CORRESP
- Filer
- Verrica Pharmaceuticals Inc. (VRCA) (CIK 0001660334)
- CIK
- 0001660334
- Ticker
- VRCA
- Filed
- 2025-12-19
- SIC industry
- 2834
- HQ
- West Chester, PA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1660334/000119312525326765/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗